Global Human Immunodeficiency Virus (HIV) Market: Industry Analysis & Outlook (2017-2021)

1
Industry Research by Koncept Analytics
Global Human Immunodeficiency Virus (HIV) Market
Industry Analysis Outlook ---------------------
-------------------- (2017-2021)
May 2017
2
Executive Summary
HIV (Human immunodeficiency virus) is a
retrovirus which causes HIV infection and attacks
the CD-4 cells (T-cells) in the immune system of
human body. HIV reduces the number of T-cells in
the body and makes the immune system vulnerable
to life-threatening infections and cancers. An
infected person cannot get rid of this virus
properly but its effects can be reduced with the
treatment. HIV does not get spread easily into
human. Only certain body fluids of an infected
person can transmit HIV into others. HIV never
gets transmitted through casual contacts like
handshakes, sharing food or water. It has certain
transmission ways including blood transmission of
an infected person to non-infected person,
exchange of body fluids like semen, pre-seminal
or vaginal fluids during unprotected physical
contacts and from a mother to child during
pregnancy or breastfeeding. HIV therapeutics
market is likely to witness a growth with
increasing demand for single tablet regimens and
growth of HIV diagnostic market is expected to be
driven by increasing technological advancements
in diagnosis tests. Middle East and Africa are
the major contributors to the global HIV market
supported by increased prevalence of HIV due to
rising drug abuse and unprotected physical
contacts among adolescents. Asia-Pacific is
likely to experience further growth of HIV market
due to recent development in HIV treatments. The
global HIV market is expected to grow in future
due to decreasing HIV related death rates, low
awareness of HIV transmission and government
initiatives to promote HIV treatment. Key trends
of this market include progressing HIV drug under
pipeline, increasing adoption of STR and
Development of technologically advanced
diagnostic products. However, there are some
factors which can hinder growth of the market
including decreasing global HIV funds, social
stigma and discrimination and treatment
failures. The report Global HIV Market Industry
Analysis Outlook (2017-2021) by Koncept
Analytics provides an extensive research and
detailed analysis of the present market along
with future outlook. The report discusses the
major growth drivers and challenges of the
market, covering the U.S along with the global
market. The report profiles players of the market
including Johnson Johnson, Merck and Co.,
Gilead and GlaxoSmithKline Plc.
3
Global HIV therapeutics market is likely to grow
with the rising awareness of HIV treatments and
increasing demand for single tablet regimens
Global HIV Therapeutics Market Forecast by Value
(2016-2021)

• Global HIV therapeutics market is expected to
  reach US.. billion in 2021, increasing from
  US.. billion in 2016, recording growth at a
  CAGR of ...
• In 2016, integrase inhibitor held a share of ..
  of the global HIV therapeutics market followed by
  NNRTI with a share of ...
• In 2016, the global integrase inhibitor market
  reached US.. billion and is expected to reach
  US.. billion in 2021, growing at a CAGR of .

Global Integrase Inhibitor Market Forecast by
Value (2016-2021)
Global HIV Therapeutics Market by Drug Class
(2016)
4
Global HIV diagnostic market growth is likely to
be driven by rising technological advancements in
diagnostic tests
Global HIV Diagnostic Market Forecast by Value
(2016-2021)

• By the year 2021, global HIV diagnostic market is
  expected to reach US.. million increasing from
  US.. million in 2016, at a CAGR of ...
• In 2016, CD4 tests held a share of .. of the
  global HIV diagnostic market followed by viral
  load tests holding a share of ...
• In 2021, global HIV patient population is
  expected to reach ..million people increasing
  from ..million people in 2017, at a CAGR of ...

Global HIV Patient Population Forecast (2017-2021)
Global HIV Diagnostic Market by Type (2016)
5
Disclaimer
Contact Us
This is a licensed product of Koncept Analytics.
You cannot reproduce, publish, distribute,
publicly display, sell or create other works from
this report or use them in any way for commercial
purpose without our prior permission. Further,
you cannot copy this material, by any means
(including electronic copies), for distribution
to others unless you have purchased the corporate
license of this report. We believe the sources
are reliable, but Koncept Analytics does not
warranty the accuracy or completeness of the
data. The data presented in the report is updated
at the publication date but is subject to change
at subsequent releases. All possible efforts have
been made to ensure accuracy of data. However,
investors should not completely rely on the
information given in this report and must make
decisions based on their own investment strategy,
risk management and capital adequacy.
Koncept Analytics CS-36, First Floor, Ansal
Plaza Vaishali, Ghaziabad, U.P. 201010 T
91-120-4130959 M 91-9811715635
vikas_at_konceptanalytics.com
www.konceptanalytics.com